Streetbeat News

Analyst Ratings

EW

RBC Capital analyst Shagun Singh maintains an Outperform rating on Edwards Lifesciences but lowers the price target from $85 to $75.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:40 pm

DXCM

RBC Capital analyst Shagun Singh maintains an Outperform rating on DexCom (NASDAQ:DXCM) but lowers the price target from $130 to $120.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:38 pm

BSX

RBC Capital analyst Shagun Singh has maintained an 'Outperform' rating on Boston Scientific and raised the price target from $85 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:37 pm

ABT

RBC Capital analyst Shagun Singh maintains an Outperform rating on Abbott Laboratories and raises the price target from $125 to $130.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:35 pm

TCOM

HSBC analyst Parash Jain has downgraded Trip.com Group (NASDAQ:TCOM) from a Buy to a Hold rating.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:31 pm

DAL

Bernstein analyst David Vernon maintains an Outperform rating on Delta Air Lines and raises the price target from $62 to $65.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:27 pm

HUM

Bernstein analyst Lance Wilkes has upgraded Humana (NYSE:HUM) from Market Perform to Outperform, setting a price target of $308.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:22 pm

ZBIO

Jefferies has initiated coverage on Zenas BioPharma with a Buy rating and set a price target of $35.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:21 pm

BTDR

Alliance Global Partners has initiated coverage on Bitdeer Technologies with a Buy rating and set a price target of $14.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:19 pm

MBX

Jefferies has initiated coverage on MBX Biosciences with a Buy rating and set a price target of $35, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:19 pm